Recomienda este artículo a tus amigos:
Specification of Drug Substances and Products: Development and Validation of Analytical Methods Christopher M. Riley 2.º edición
Specification of Drug Substances and Products: Development and Validation of Analytical Methods
Christopher M. Riley
Presents a critical analysis of the requirements and approaches to setting specifications for the new pharmaceutical products, with an emphasis on phase-appropriate development and validation of analytical methods. This title offers a guide to industry practices of analytical methodologies used in the specification of drug substances and products.
390 pages, Illustrated
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 17 de septiembre de 2013 |
| ISBN13 | 9780080983509 |
| Editores | Elsevier Health Sciences |
| Páginas | 390 |
| Dimensiones | 192 × 243 × 21 mm · 970 g |
| Editor | Riley, Christopher M. (President of Riley and Rabel Consulting Services, Maryville,MO,USA.) |
| Editor | Rosanske, Thomas W. (Consultatnt, Lee's Summit, MO, USA) |